Prosecution Insights
Last updated: October 25, 2026

3Helix Inc.

Technology area: Medical Devices & Mechanical Engineering

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

3Helix Inc. operates a company patent portfolio in the Medical Devices & Mechanical Engineering technology area. There are 2 pending office actions currently active for this portfolio. These actions are distributed among 2 distinct examiners. Additionally, the matters are being processed within 2 distinct art units, which suggests a lack of administrative or technical overlap between the current pending cases. For a patent practitioner, this means that prosecution strategies must be tailored to 2 different individuals across 2 distinct art units.

The busiest examiner identified is ORWIG, KEVIN S, who is currently managing 1 busiest examiner pending action. Given the total of 2 pending office actions, ORWIG, KEVIN S is responsible for a portion of the active docket. The remaining portion is handled by the other of the 2 distinct examiners. This structure implies that the Medical Devices & Mechanical Engineering innovations currently under review are diverse enough to be assigned to different specialized units within the patent office. Practitioners should prepare for independent timelines and examination styles for each of the 2 pending office actions due to the lack of overlap in examiners and art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
50% of docket
1
Business / Other
50% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ORWIG, KEVIN S 1 25.5% +40.1%
SANTOS RODRIGUEZ, JOSEPH M 1 69.7% +26.4%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18688621 Systems and Methods for Detecting Fibrosis SANTOS RODRIGUEZ, JOSEPH M 46d overdue
18698649 Biologically Active Collagen Hybridizing Peptides ORWIG, KEVIN S —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18688621 Systems and Methods for Detecting Fibrosis SANTOS RODRIGUEZ, JOSEPH M 46d overdue
18698649 Biologically Active Collagen Hybridizing Peptides ORWIG, KEVIN S —

Top Art Units

Art UnitApps
3991 1
3797 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18698649 Biologically Active Collagen Hybridizing Peptides ORWIG, KEVIN S 3991 §102§103§112 Non-Final OA — Pending Apr 04, 2024
18688621 Systems and Methods for Detecting Fibrosis SANTOS RODRIGUEZ, JOSEPH M 3797 §103§112 Final Rejection 46d overdue Pending Mar 01, 2024

Managing 3Helix Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does 3Helix Inc. have?

3Helix Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most 3Helix Inc. applications?

Kevin S Orwig has the most, with 1 of 3Helix Inc.'s pending office actions.

What technology area are 3Helix Inc.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month